Enanta Pharmaceuticals
Price & Volume
Stats
See moreOpen | $13.73 |
Previous Close | $13.81 |
Day Range | $12.73-$13.73 |
52W Range | $6.60-$17.15 |
Market Cap | $400.4M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $69.2M |
Revenue Growth (YoY) | 15% |
Gross Profit (12 Mos) | $69.2M |
Diluted EPS | -$2.60 |
News
See moreYahoo Finance • 2 months ago
Pfizer patent win against Enanta over COVID pill upheld by appeals court
Yahoo Finance • 2 months ago
Enanta Pharmaceuticals’ Partner AbbVie Receives European Commission Approval of MAVIRET® (Glecaprevir/Pibrentasvir) for People with Acute Hepatitis C Virus
Yahoo Finance • 2 months ago
What to Know About This Fund's $5.4 Million Ultragenyx Purchase as Shares Slip 30% in One Year
Yahoo Finance • 9 months ago
Enanta rises as J.P. Morgan starts at Overweight on RSV therapy
About
CEO | Dr. Jay R. Luly Ph.D. |
Address | 4 Kingsbury Avenue, Watertown, MA, United States, 02472 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 120 |